ConductScience.org, home

Paper42762003

Derivation and Exploratory Evaluation of the Respiratory Rate-Oxygenation (ROX) Index as a Predictor of High-Flow Nasal Cannula Outcomes in Patients With COVID-19 Pneumonia.

Chandra R and 6 others. Cureus, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Derivation and Exploratory Evaluation of the Respiratory Rate-Oxygenation (ROX) Index as a Predictor of High-Flow Nasal Cannula Outcomes in Patients With COVID-19 Pneumonia. Papers, record 42762003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42762003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Derivation and Exploratory Evaluation of the Respiratory Rate-Oxygenation (ROX) Index as a Predictor of High-Flow Nasal Cannula Outcomes in Patients With COVID-19 Pneumonia.
PubMed
Journal
Cureus
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chandra RRajesh
2Ankita
3Kumar HHarish
4Kumar SSandeep
5Kaushal AAshutosh
6Jain AAnuj
7Sinha NNitesh

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133201321The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline.Intensive Care Med2020https://conductscience.org/library/papers/33201321PubMed
228780231
The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis.
Am J Emerg Med2018https://conductscience.org/library/papers/28780231PubMed
330576221An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.Am J Respir Crit Care Med2019https://conductscience.org/library/papers/30576221PubMed
425981908High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.N Engl J Med2015https://conductscience.org/library/papers/25981908PubMed
534548669Utility of the ROX Index in Predicting Intubation for Patients With COVID-19-Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study.JMIRx Med2021https://conductscience.org/library/papers/34548669PubMed
68844239
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.
Intensive Care Med1996https://conductscience.org/library/papers/8844239PubMed
732758000High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19.Am J Respir Crit Care Med2020https://conductscience.org/library/papers/32758000PubMed
834634500ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.Respir Med2021https://conductscience.org/library/papers/34634500PubMed
927481760Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.J Crit Care2016https://conductscience.org/library/papers/27481760PubMed
1032250385Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.JAMA2020https://conductscience.org/library/papers/32250385PubMed
1133328179High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.Respir Care2021https://conductscience.org/library/papers/33328179PubMed
1225691263Failure of high-flow nasal cannula therapy may delay intubation and increase mortality.Intensive Care Med2015https://conductscience.org/library/papers/25691263PubMed
1332109013Clinical Characteristics of Coronavirus Disease 2019 in China.N Engl J Med2020https://conductscience.org/library/papers/32109013PubMed
1434507079ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: A systematic review and meta-analysis.J Crit Care2021https://conductscience.org/library/papers/34507079PubMed
1532983456High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19.Multidiscip Respir Med2020https://conductscience.org/library/papers/32983456PubMed
1634799658Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia.Sci Rep2021https://conductscience.org/library/papers/34799658PubMed
1732587703Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate.J Intensive Care2020https://conductscience.org/library/papers/32587703PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42762003

GET https://conductscience.org/api/papers/v1/42762003/authors